Targeting methyltransferase-like 5-mediated sphingomyelin metabolism: A novel therapeutic approach in gastric cancer

doi:10.4251/wjgo.v16.i10.4060

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (514)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

387

Sum=406

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=83

Oct 15, 2024 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4060-4063
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4060

Targeting methyltransferase-like 5-mediated sphingomyelin metabolism: A novel therapeutic approach in gastric cancer

Jin-Juan Zhang, Chang Yuan, Sheng-Chun Dang

Jin-Juan Zhang, Chang Yuan, Sheng-Chun Dang, Department of General Surgery, The Affiliated Hospital of Jiangsu University, Zhenjiang 212001, Jiangsu Province, China

Co-first authors: Jin-Juan Zhang and Chang Yuan.

Author contributions: Zhang JJ, Yuan C, and Dang SC wrote the manuscript; all authors have read and approved the final manuscript.

Supported by Jiangsu Commission of Health, No. LKZ2023012; and Social Development Project of Zhenjiang City, No. SS2023011.

Conflict-of-interest statement: All the authors have no relevant conflict of interest to disclose.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Sheng-Chun Dang, Doctor, Professor, Surgeon, Department of General Surgery, The Affiliated Hospital of Jiangsu University, No. 438 Jiefang Road, Zhenjiang 212001, Jiangsu Province, China. dscgu@163.com

Received: April 5, 2024
Revised: May 17, 2024
Accepted: June 5, 2024
Published online: October 15, 2024
Processing time: 174 Days and 5.6 Hours

Core Tip

Core Tip: This study comprehensively analyzes the role of methyltransferase-like 5 (METTL5) in the progression of gastric cancer (GC), highlighting its potential as a new therapeutic target and prognostic biomarker. However, further research is needed to fully understand the functional mechanism of METTL5 in GC and translate these insights into clinical applications. Targeting METTL5-mediated sphingomyelin metabolism is a novel therapeutic approach in GC.